Abstract:Background. The expression of ZFP36 in previous study was reduced in prostate cancer (PCa) tissues as compared to benign prostate tissues, indicating the potential of ZFP36 as an auxiliary marker for PCa. Further evaluation was conducted in clinical samples for in vitro and in vivo experiments, to prove the potential possibility that ZFP36 dysregulation participated in the malignant phenotype of PCa, to determine its potential mechanism for tumor regulation, and to provide a new theoretical basis for gene therapy of PCa. Methods. First, the expression of ZFP36 in prostate tissue and PCa tissue was explored, and the relationship between ZFP36 and clinical features of PCa patients was illustrated. Subsequently, the impact of ZFP36 on the biology of PCa cells and relevant downstream pathways of ZFP36’s biological impact on PCa were elucidated. Finally, whether oxidative stress mediated the regulation of ZFP36 in PCa was verified by the determination of oxidative stress-related indicators and bioinformatics analysis. Results. The downregulation of ZFP36 in PCa tissue had a positive correlation with high Gleason scores, advanced pathological stage, and biochemical recurrence. ZFP36 was identified as an independent prognostic factor for PCa patients’ BCR-free survival ( P = 0.022 ) by survival analysis. Following a subsequent experiment of function gain and loss, ZFP36 inhibited the proliferation, invasion, and migration in DU145 and 22RV1 cells and inhibits tumor growth in the mouse model. Additionally, high-throughput sequencing screened out CDK6 as the downstream target gene of ZFP36. Western blot/Q-PCR demonstrated that overexpression of ZFP36 could reduce the expression of CDK6 at both cellular and animal levels, and the dual-luciferase experiment and RIP experiment proved that CDK6 was the downstream target of ZFP36, indicating that CDK6 was a downstream target of ZFP36, which mediated tumor cell growth by blocking cell cycle at the G1 stage. Furthermore, ZFP36 inhibited oxidative stress in PCa cells. Conclusions. In PCa, ZFP36 might be a tumor suppressor that regulated growth, invasion, and migration of PCa cells. The lately discovered ZFP36-CDK6 axis demonstrated the molecular mechanism of PCa progression to a certain extent which might act as a new possible therapeutic target of PCa therapy.

Role of PLZF As a Tumor Suppressor in Prostate Cancer

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

The Promyelocytic Leukemia Zinc Finger Protein: Two Decades of Molecular Oncology

Plzf Mediates The Pten/Akt/Foxo3a Signaling In Suppression Of Prostate Tumorigenesis

Tumor-suppressive Functions of Leucine Zipper Transcription Factor-Like 1.

Functions of PLZF in Male Germline Stem Cell Development and Differentiation

Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis

Prlz Is Expressed In Normal Prostate Development And In Human Prostate Cancer Progression

PrLZ Regulates EMT and Invasion in Prostate Cancer Via the TGF-β1/p-smad2/miR-200 Family/zeb1 Axis

Hypermethylation Reduces Expression of Tumor‐suppressor PLZF and Regulates Proliferation and Apoptosis in Non‐small‐cell Lung Cancers

HNF1B-mediated Repression of SLUG is Suppressed by EZH2 in Aggressive Prostate Cancer

Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer

Knockdown of Zinc Finger Protein X-linked Inhibits Prostate Cancer Cell Proliferation and Induces Apoptosis by Activating Caspase-3 and Caspase-9

The role of KLF transcription factor in the regulation of cancer progression

ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway

PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2

Functions of Promyelocytic Leukaemia Zinc Finger (plzf) in Male Germline Stem Cell Development and Differentiation.

Transcription Variants of the Prostate-Specific PrLZ Gene and Their Interaction with 14-3-3 Proteins.

ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

The Biological Roles of ZKSCAN3 (ZNF306) in the Hallmarks of Cancer: from Mechanisms to Therapeutics

PLZF Protein Forms a Complex with Protein TET1 to Target TCF7L2 in Undifferentiated Spermatogonia